Add BrightSurf on Google Email

Search results for “Oncology”

1,000+ results for "Oncology"

Exploring the effects of integrative health in cancer

A Special Focus Issue on Integrative Oncology investigates complementary and integrative medicine in multiple age groups, nations, and special populations. Research articles and commentaries discuss the options and effectiveness of nutritional strategies, aromatherapy, massage, and self-care toolkits for cancer patients.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalThe Journal of Alternative and Complementary Medicine·DateSep 24, 2018

ESMO 2018 awardees announced

The ESMO Award 2018 is bestowed on Jean-Charles Soria, a pioneer in developing anti-cancer drugs, while Tony Mok receives the ESMO Lifetime Achievement Award for his practice-changing contribution to lung cancer. Pasi Jänne and Margaret Foti also receive awards for their translational research and mentorship efforts, respectively.

Idera Pharmaceuticals presents clinical data from the ILLUMINATE-204 trial of the combination of tilsotolimod and ipilimumab for anti-PD-1 refractory metastatic melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

The ILLUMINATE-204 trial shows an overall response rate of 38% with 2 complete responses, suggesting a promising strategy for treating patients with metastatic melanoma unresponsive to PD-1 therapy. The combination regimen is generally well-tolerated, with fewer than a quarter of patients experiencing immune-related toxicities.

Study finds medical students receive little formal instruction in radiation oncology

A recent study found that medical students receive little formal instruction in radiation oncology, a crucial aspect of cancer treatment. The study highlights the need for radiation oncologists to take ownership over educating medical students about their specialty's value in patient care. Despite this gap, some departments reported en...

SourceLoyola Medicine·JournalJournal of the American College of Radiology·DateMar 22, 2018

International organizations partner to spread awareness of revised lung cancer staging criteria

International organizations IASLC and BTOG are partnering to spread awareness of revised lung cancer staging criteria. The new system takes effect this month and aims to provide better care for patients. Key findings highlight improved prognostic factors, tumor size measurements, and coding systems for lung cancers with multiple lesions.

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJan 23, 2018

Trastuzumab: No negative impact on cardiac function

The NRG Oncology trial found that trastuzumab did not negatively affect cardiac function in patients with node-positive, HER2-positive breast cancer who survived without cancer recurrence. Both groups maintained good cardiac function at a median of 8.8 years after treatment.

SourceNRG Oncology·JournalJournal of Clinical Oncology·DateJan 3, 2018

First line combination therapy improves progression-free survival in advanced lung cancer

The combination of chemotherapy and immunotherapy significantly improves progression-free survival in patients with advanced non-squamous NSCLC. The study showed that the addition of atezolizumab to bevacizumab and chemotherapy leads to a median PFS of 8.3 months, compared to 6.8 months with bevacizumab and chemotherapy alone.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateDec 7, 2017

The Lancet Oncology: Major report sets out how to accelerate cancer research and care, delivering on US Cancer Moonshot initiative

The Lancet Oncology Commission recommends prioritizing key areas for US$2 billion funding to advance cancer research and treatment, focusing on prevention, targeted interventions, and patient-centered data sharing. The report aims to improve cancer care for underserved groups and reduce health disparities.

SourceThe Lancet·JournalThe Lancet Oncology·DateOct 31, 2017